Literature DB >> 23617340

Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

Peter Storz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23617340      PMCID： PMC3800143          DOI： 10.1586/era.13.28

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  24 in total

1.  Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.

Authors:  Y Yang; S Fang; J P Jensen; A M Weissman; J D Ashwell
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

2.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

Authors:  G Xiao; E W Harhaj; S C Sun
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 3.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 4.  NF-κB inducing kinase: a key regulator in the immune system and in cancer.

Authors:  Yee Mon Thu; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-03       Impact factor: 7.638

5.  IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.

Authors:  Günter Schneider; Dieter Saur; Jens T Siveke; Ralph Fritsch; Florian R Greten; Roland M Schmid
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

6.  Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

Authors:  Steffan T Nawrocki; Jennifer S Carew; Maria S Pino; Ralph A Highshaw; Robert H I Andtbacka; Kenneth Dunner; Ashutosh Pal; William G Bornmann; Paul J Chiao; Peng Huang; Henry Xiong; James L Abbruzzese; David J McConkey
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

7.  TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation.

Authors:  Wen-Hui Hu; Xian-Ming Mo; Winston M Walters; Roberta Brambilla; John R Bethea
Journal:  J Biol Chem       Date:  2004-06-18       Impact factor: 5.157

8.  Increased expression of NF-kappa B subunits in human pancreatic cancer cells.

Authors:  Nicole M Chandler; Jonathan J Canete; Mark P Callery
Journal:  J Surg Res       Date:  2004-05-01       Impact factor: 2.192

9.  The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site.

Authors:  Gladys de Leon-Boenig; Krista K Bowman; Jianwen A Feng; Terry Crawford; Christine Everett; Yvonne Franke; Angela Oh; Mark Stanley; Steven T Staben; Melissa A Starovasnik; Heidi J A Wallweber; Jiansheng Wu; Lawren C Wu; Adam R Johnson; Sarah G Hymowitz
Journal:  Structure       Date:  2012-08-23       Impact factor: 5.006

10.  Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity.

Authors:  Heike Döppler; Geou-Yarh Liou; Peter Storz
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240
View more
  10 in total

1.  Expression of NF-κB-inducing kinase in breast carcinoma tissue and its clinical significance.

Authors:  Xuliang Zhang; Yong Wang; Zheyu Mao; Danqing Huang; Junwei Zhou; Xudong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells.

Authors:  Baoyue Ding; Md Arif Wahid; Zhijun Wang; Chen Xie; Arvind Thakkar; Sunil Prabhu; Jeffrey Wang
Journal:  Nanoscale       Date:  2017-08-17       Impact factor: 7.790

Review 3.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

Review 4.  Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications.

Authors:  Shan Jin; Oyungerel Borkhuu; Wuyuntu Bao; Yun-Tian Yang
Journal:  J Clin Med Res       Date:  2016-02-27

5.  Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers.

Authors:  Nahoum G Anthony; Jessica Baiget; Giacomo Berretta; Marie Boyd; David Breen; Joanne Edwards; Carly Gamble; Alexander I Gray; Alan L Harvey; Sophia Hatziieremia; Ka Ho Ho; Judith K Huggan; Stuart Lang; Sabin Llona-Minguez; Jia Lin Luo; Kathryn McIntosh; Andrew Paul; Robin J Plevin; Murray N Robertson; Rebecca Scott; Colin J Suckling; Oliver B Sutcliffe; Louise C Young; Simon P Mackay
Journal:  J Med Chem       Date:  2017-08-15       Impact factor: 7.446

6.  Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.

Authors:  Seung Tae Kim; Sun Young Kim; Jeeyun Lee; Kyung Kim; Se Hoon Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Joon Oh Park
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430

7.  Nuclear factor κB -inducing kinase is a diagnostic marker of gastric cancer.

Authors:  Hairong Teng; Liang Xue; Yuexia Wang; Xian Ding; Jiaxin Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

8.  Maslinic Acid, a Triterpene from Olive, Affects the Antioxidant and Mitochondrial Status of B16F10 Melanoma Cells Grown under Stressful Conditions.

Authors:  Khalida Mokhtari; Eva E Rufino-Palomares; Amalia Pérez-Jiménez; Fernando J Reyes-Zurita; Celeny Figuera; Leticia García-Salguero; Pedro P Medina; Juan Peragón; José A Lupiáñez
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-07       Impact factor: 2.629

9.  Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.

Authors:  Cheng Wang; Biao Liu; Xuelian Xu; Bo Zhuang; Hongxia Li; Jiaqi Yin; Mengyi Cong; Wei Xu; Aiping Lu
Journal:  Oncotarget       Date:  2016-02-16

10.  Whole-Genome Profiles of Malay Colorectal Cancer Patients with Intact MMR Proteins.

Authors:  Wan Khairunnisa Wan Juhari; Khairul Bariah Ahmad Amin Noordin; Andee Dzulkarnaen Zakaria; Wan Faiziah Wan Abdul Rahman; Wan Muhamad Mokhzani Wan Muhamad Mokhter; Muhammad Radzi Abu Hassan; Ahmad Shanwani Mohammed Sidek; Bin Alwi Zilfalil
Journal:  Genes (Basel)       Date:  2021-09-20       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.